19 hrs ago | fool.com
Don't let it get away! Keep track of the stocks that matter to you. Help yourself with the Fool's FREE and easy new watchlist service today. If the JPMorgan Healthcare Conference in January is the mecca of all health-care...
Read more...
Sean Williams PD-1 immunotherapy immunotherapeutic Dendreon ASCO cancer patient IDO1 Lambrolizumab drug Nivolumab MPDL3280A early-stage stock response Provenge
11 hrs ago | prweb.com
Roy A. Patchell, MD, Chair, Department of Neurology, University of Arizona-Phoenix College of Medicine, and Chair, Division of Neurology, Barrow Neurological Institute, St. Joseph’s Hospital and... (PRWeb May 24, 2013) Read the...
Read more...
Audio-Digest Neurological oncology WBRT Neurology Medicine metastasis 04 Arizona-Phoenix Medical Surgery foundation Chair volume Patchell Neuro-Oncology MD Jefferson brain
22 hrs ago | invivoblog.blogspot.cz
With the oncology high season upon us and just about everyone in the industry scrambling to decode the secrets hidden in ASCO’s abstracts, we couldn’t help but stop and reflect on how at least one company got where it is in...
Read more...
Medarex Zoetis Xellia Bristol Actavis GSK Novo elan BTG Pfizer BARDA deal Therasphere
May 23, 2013 | retractionwatch.wordpress.com
The editor of Clinical Medicine Insights: Oncology has issued an Expression of Concern over a 2008 paper by a group of authors in China after identifying “flaws” in one of the figures. The article, “Exvivo experiments of human...
Read more...
journal cord Expression Concern oncology Exvivo exosomes ascites-derived blood dendritic paper immunotherapy umbilical ovarian COPE figure 10.4137 CMO.S776 Yue-Cheng 2008;2;461 Qi-Ling
May 23, 2013 | physorg.com
—New tension gauge tether (TGT) laboratory method developed at the University of Illinois at Urbana-Champaign has broad applications for research into stem cells, cancer, infectious disease, and immunology.
Read more...
cell pN adhesion integrin biophysicist tether University of Illinois molecular activate tension ligand TGT pico-Newtons strand integrin-ligand molecule cellular Wang tolerance
May 23, 2013 | firmenpresse.de
College of Pharmacy Partners With TNI BioTech to Develop New Drugs for Africa (firmenpresse) - WASHINGTON, DC -- (Marketwired) -- 05/23/13 -- Howard University College of Pharmacy has signed a multi-year agreement with TNI...
Read more...
BioTech TNI Pharmacy Howard Africa drug College pharmaceutical
May 23, 2013 | bbc.co.uk
They were thought to clear a path for cancer cells, but now MMP enzymes have been shown to help the immune system attack the tumour Enzymes released by cancerous cells have a protective function and are not one of the "bad...
Read more...
All similar articles: 62 »
MMP-8 enzyme cancer cell tumor breast immune cop MMPs IL-8
May 23, 2013 | bio-medicine.org
BETHESDA, Md. , May 23, 2013 /- Northwest Biotherapeutics (NASDAQ: NWBO ) (NW Bio), a biotechnology company developing DCVax ® personalized immune therapies for solid tumor cancers, announced today that it will use its exhibit...
Read more...
ASCO Bio NW Exhibit DCVax immune therapy oncologist tumor cancer
19 hrs ago | bio-medicine.org
Cancer cells spread and grow by avoiding detection and destruction by the immune system. Stimulation of the immune system can help to eliminate cancer cells; however, there are many factors that cause the immune system to...
Read more...
immune metastatic cancer cell tumor system T antibody regulatory metastasis OX-40 Ghirelli target CTLA-4
May 24, 2013 | voxy.co.nz
The University of Otago will this weekend confer the honorary degree of Doctor of Science on Professor Helen Heslop, an Otago graduate who has forged an outstanding medical and research career overseas.
Read more...
Heslop Otago Professor therapy Doctor leading Transplantation Squire
May 24, 2013 | prostate.net
What Is Advanced Metastatic Prostate Cancer “What is advanced metastatic prostate cancer?” is something you may wonder if you have prostate cancer. Metastatic prostate cancer is when cancer has spread from the prostate to...
Read more...
All similar articles: 139 »
prostate metastatic cancer Provenge advanced
22 hrs ago | prostate.net
Cost of Provenge What is the cost of Provenge (sipuleucel-T)? Men with late-stage prostate cancer that has spread after hormone therapy or surgery may want to ask about the cost of treatment to help them make medical decisions....
Read more...
Provenge patient cost Dendreon co-pays PROvide co-insurance deductible
May 22, 2013 | finance.yahoo.com
NEW YORK, May 22, 2013 /PRNewswire/ -- The Cancer Research Institute (CRI), a New York-based nonprofit organization committed to developing immune system-based cancer treatments, is holding a series of ...
Read more...
All similar articles: 166 »
immunotherapy cancer Presented June CRI research treatment fightwithwhite webinars www.cancerresearch.org Institute
May 22, 2013 | barrons.com
By Sam Mamudi Bristol-Myers Squibb stock is up more than 7% today, and leading the Standard & Poor’s 500 index, thanks in part to a Citi Research note which upgraded the company to Buy and raised the stock’s price target to $55...
Read more...
Sam Mamudi Bristol-Myers Citi BMY immunotherapy stock CAGR BMS 2026 7 Baum $55 FY14e Smarten
May 22, 2013 | bullfax.com
By The Swiss Trader : In April the global health care giant Merck & Co. ( MRK ) , received "breakthrough therapy designation" from the U.S. Food and Drug Administration (FDA) for its investigational antibody therapy ,...
Read more...
PD-1 designation therapy breakthrough immune drug cell receive Lambrolizumab camouflage checkpoint tumor tumor-specific protein Programmed immunomodulatory
May 22, 2013 | fool.com
As new immunotherapy drugs hope to turn metastatic cancer into a chronic manageable condition, or at least significantly prolong life in the near term, investors are understandably excited about their potential. And one company...
Read more...
David Williamson Wall Street MotleyDavid Obamacare Bristol upgrade immunotherapy $33 Bristol-Myers Squibb metastatic Need to takeaways $55 Motley far-reaching titan understandably Williamson Fool manageable health-care prolong investor Citi Know David health forefront
May 22, 2013 | finance.yahoo.com
Immunovaccine Reports Financial Results for First Quarter of 2013 On May 16, 2013, Immunovaccine Inc. (TSXV: IMV .V) announced its financial and operational results for the quarter ended March 31, 2013. There was no revenue for...
Read more...
DPX-Survivac Immunovaccine Phase IMV patient vaccine immune clinical vaccination trial cancer study RSV
May 21, 2013 | finance.yahoo.com
Amgen Inc. (AMGN) UBS Global Healthcare Conference Call May 21, 2013 10:00 a.m. ET Executives Joseph P. Miletich - Senior Vice President of Research and Development Analysts Matthew Roden - UBS Presentation ...
Read more...
study Phase molecule Amgen program actually patient deCODE UBS cell tumor II AMG receptor antibody disease
May 23, 2013 | finance.yahoo.com
By Grant Zeng, CFA NWBO Reports First Quarter of 2013 Financials On May 16, Northwest Biotherapeutics (Nasdaq-small:NWBO) filed its 10-Q for the first quarter of 2013. There was no revenue for the first ...
Read more...
DCVax-Direct NWBO tumor DCVax-L cancer trial Phase DCVax®-Direct
May 22, 2013 | finance.yahoo.com
Celgene Corporation (CELG) 2013 UBS Global Healthcare Conference Call May 22, 2013, 11:30 am ET Executives Perry Karsen - EVP & COO Analysts Matt Roden - UBS Presentation Matt Roden - UBS Hi good morning ...
Read more...
apremilast POMALYST Celgene ABRAXANE REVLIMID psoriatic psoriasis pancreatic patient 2017 UBS franchise hematology oncology growth data arthritis cancer
May 21, 2013 | sbwire.com
MarketResearchReports.Biz announces addition of new report “Therapeutic Vaccines Market - Global Industry Analysis, Market Share, Size, Growth, Trends, and Forecast, 2012 - 2018” to its database ) -- 05/21/2013 --...
Read more...
Marketresearchreports.Biz By-Marketresearchreportsbiz vaccine therapeutic analysis growth 2018 www.marketresearchreports.biz segment industry global Market It size MarketResearchReports.Biz
May 22, 2013 | healthcanal.com
The body's own immune system’s fight against breast cancer is controlled by genetic ‘fine tuners’, known as microRNAs, according to a study published in Nature today1. Looking at 1,300 breast cancer samples, Cancer Research UK...
Read more...
cancer tuner genetic breast microRNAs subtype control fine body immune Research UK
May 22, 2013 | pr-inside.com
Advaxis, Inc., (Advaxis) is a biotechnology company. It develops next generation immunotherapies for cancer and infectious diseases. The company is developing products for the treatment of cervical, breast, prostate, ovarian,...
Read more...
All similar articles: 1067 »
Advaxis deal ADXS Pharmaceuticals&Healthcare GlobalData profile key Mergers Acquisitions research cancer Equity
May 22, 2013 | redliontrader.com
Post navigation ← felixsalmon: A timely reminder that it’s not just Apple: they all do it. http://t.co/3JQYNIMiAu There’s A Huge Flaw In Yahoo’s Monetization Plan For Tumblr (YHOO) → PALO ALTO, Calif., May 22, 2013 /PRNewswire/...
Read more...
Twitterfeed Enzoani CBMG TC-DC GEDC patient cell t.co Behrmann therapy Biomedicine Yenter
May 21, 2013 | fox59.com
May is Skin Cancer Awareness Month and there is a big push for people to take proper precautions to protect their skin. But what if there was a skin cancer vaccine to help keep skin cancer at bay? A local …
Read more...
Jenny Anchondo vaccine cancer skin 317 Schwartzentruber 338-2273 Sapp doctor immune Melanoma 777-7775 344-7800 859-3267 688-3627
May 21, 2013 | breastcancerbydrruddy.com
By Vera Viner What does cancer prevention really mean? It seems that, despite the fact that the color pink and breast cancer fundraising projects are seen all around the country, many women and even major news organizations do...
Read more...
All similar articles: 413 »
cancer mammography breast prevent preventing cellular-disrupting list woman
May 22, 2013 | medicalnewstoday.com
Using bacteria to ferry radioisotopes commonly used in cancer therapy directly into pancreatic cancer cells in mice, researchers in the US were able dramatically to reduce the number of secondary tum...
Read more...
All similar articles: 69 »
pancreatic cancer Gravekamp bacterium radioactive Listeria Dadachova tumor mouse cell spread rhenium
May 22, 2013 | yahoo.com
May 22 2013, 08:34 by: The Swiss Trader | about: MRK In April the global health care giant Merck & Co. , received "breakthrough therapy designation" from the U.S. Food and Drug Administration (FDA) for its investigational...
Read more...
All similar articles: 439 »
Swiss Trader Merck lambrolizumab drug PD-1 therapy immunotherapy designation immune breakthrough melanoma cancer novel Tredaptive
May 21, 2013 | pehub.com
Transgene SA , a biopharmaceutical company that develops targeted immunotherapy products to treat cancer and chronic infectious diseases, said on Tuesday that it has participated in a first round of financing in ElsaLys Biotech...
Read more...
Transgene Sofimac ElsaLys antibody Biotech Start-Up Pexa-Vec TG4010
May 22, 2013 | estatevaults.com
Should you be taking vitamin B to protect against Alzheimer's? Vitamins B6 , B12 and folic acid Research published yesterday in the top journal Proceedings of the National Academy of Sciences, which showed that people in the...
Read more...
All similar articles: 49 »
shrinkage brain bunion CPR cancer apigenin B drug protect Alzheimer vitamin camomile health cell